Pratia Hosts Webinar to Reduce Delays in Oncology Trials
News fromCourierPR · 3 min read
Pratia, a clinical research organization, is hosting a webinar aimed at reducing delays in complex oncology trials from study start-up to patient recruitment.
The webinar will feature experts from Pratia and the oncology field. Chloe Rose, PhD, Vice President of Site Solutions at Pratia, will lead the discussion alongside Julio Peguero, MD, Medical Oncologist and President and Executive Chairman of P1 Pratia Oncology, and Santiago Viteri, MD, PhD, Medical Oncologist and CEO of Pratia Sirius. Lauren Stockwell, Associate Director of Education & Engagement at the Society for Clinical Research Sites (SCRS), will also participate.
The discussion will cover several key areas critical to the success of oncology trials. Featured speakers will explore the importance of early site engagement and stronger feasibility studies in improving site selection and uncovering operational barriers. They will also delve into the differences between Phase I and later-phase recruitment, including patient identification strategies for biomarker-driven studies.
Attendees will gain insights into how referral pathways, site capabilities, and regional differences across the United States and Europe can impact enrollment planning. The webinar aims to provide practical guidance for sponsors and contract research organizations (CROs) to enhance patient recruitment strategies and ensure smoother trial execution.
The webinar is part of Xtalks' ongoing efforts to provide valuable insights and practical solutions for the life sciences community. Xtalks empowers professionals across pharma, biotech, medtech, healthcare, and research with trusted knowledge and collaborative insights that drive the industry forward.
TORONTO, Sept. 18, 2026 /PRNewswire/, Complex oncology trials put pressure on every stage of study execution, from selecting and preparing the right sites to finding eligible patients in increasingly specific populations. What can sponsors and CROs do to reduce avoidable delays and make recruitment more predictable? In this webinar, the featured speakers will explore how early site engagement and stronger feasibility can improve site selection, uncover operational barriers sooner, and support successful enrollment across early- and late-phase oncology studies.
As oncology trials become more biomarker-driven and patient populations harder to identify, effective pre-screening and patient identification are becoming increasingly important. The discussion will examine approaches for finding patients with specific genetic mutations and consider how referral pathways and site capabilities influence recruitment.
Patient recruitment requirements can also differ significantly across phases of development. The webinar will explore how patient identification, referral pathways, and site capabilities can vary between Phase I and later-phase studies, helping sponsors and CROs consider these differences when planning recruitment strategies. The discussion will also compare the practical realities of running oncology trials across the US and Europe.
Register for this webinar to learn how patient recruitment strategies can improve patient identification, site readiness, and enrollment across complex oncology trials. Join Chloe Rose, PhD, Vice President, Site Solutions, Pratia; Julio Peguero, MD, Medical Oncologist; President and Executive Chairman, P1 Pratia Oncology; Santiago Viteri, MD, PhD, Medical Oncologist; CEO, Pratia Sirius; and Lauren Stockwell, Associate Director, Education & Engagement, SCRS, for the live webinar on Wednesday, October 7, 2026, at 10am EDT (4pm CEST / EU-Central).
About Xtalks Xtalks, The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare, and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities, and more designed to support informed decision-making in a fast-evolving sector. Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives, and industry thought leadership. Join our life science community to stay informed, connected, and ready for what's next.